NYSE American - Delayed Quote USD
Can-Fite BioPharma Ltd. (CANF)
1.1100
-0.0050
(-0.45%)
At close: May 9 at 4:00:00 PM EDT
1.1086
-0.00
(-0.13%)
After hours: May 9 at 6:07:38 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 10.78M |
| Low Estimate | -- | -- | -- | 10.78M |
| High Estimate | -- | -- | -- | 10.78M |
| Year Ago Sales | -- | -- | 674k | -- |
| Sales Growth (year/est) | -- | -- | -100.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.52 | -0.22 | -0.24 | -0.25 |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CANF | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/15/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/21/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/20/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/18/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/18/2025 |
Related Tickers
ENLV Enlivex Therapeutics Ltd.
1.0200
-2.86%
PPBT Purple Biotech Ltd
2.2050
-0.68%
BLRX BioLineRx Ltd.
3.1700
-0.94%
PLUR Pluri Inc.
5.75
+8.29%
INAB IN8bio, Inc.
0.1574
-6.25%
IRD Opus Genetics, Inc.
0.9468
-4.92%
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
CVM CEL-SCI Corporation
0.2468
-3.14%